(CAH) Cardinal Health, Inc. Business Model Canvas Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(CAH) Cardinal Health, Inc. Bundle
Cardinal Health Business Model Canvas: Fast, Actionable Insight
Unlock the full Business Model Canvas for Cardinal Health, Inc. to see how its distribution scale, supplier relationships, and healthcare-focused value proposition work together. This concise, company-specific snapshot highlights the key drivers behind revenue, customer segments, and operational efficiency. Perfect for investors, analysts, and strategists who want actionable insight fast.
Partnerships
Pharmaceutical manufacturers
Cardinal Health’s pharmaceutical manufacturers are its core supply base, backing wholesale distribution, specialty services, and product flow across the U.S. and global markets. In fiscal 2025, Cardinal Health reported about $222.6 billion in revenue, and these branded, generic, and specialty drug ties help protect inventory availability, pricing, and continuity of supply.
Hospitals and health systems
Hospitals and health systems are key Cardinal Health, Inc. partners because they buy its pharmacy management, supply chain, and medical distribution services, while also helping shape daily workflows. Cardinal Health, Inc. reported fiscal 2025 revenue of about $222 billion, showing the scale of these provider ties as they help align inventory, clinical needs, and procurement.
Pharmacies and specialty pharmacies
Cardinal Health’s retail, mail, and specialty pharmacy partners connect it to downstream drug access, and in FY2025 the company generated about $222.6 billion in revenue. It supports these partners with distribution, repackaging, and specialty services that help keep medicines available and pharmacy operations efficient.
Healthcare suppliers and logistics providers
Cardinal Health, Inc. relies on upstream healthcare suppliers and transportation partners to source, import, warehouse, and deliver products. In fiscal 2025, Cardinal Health reported $222.6 billion in revenue, so even small delays in medical-device supply or freight can hit service levels fast.
These partnerships keep time-sensitive demand moving across hospitals, pharmacies, and surgery sites, where same-day or next-day delivery matters. Reliable logistics help protect product flow, support manufacturing inputs, and reduce stockout risk.
- Upstream sourcing keeps product supply stable.
- Logistics partners enable fast delivery.
- FY2025 revenue: $222.6 billion.
- Delays can disrupt urgent care demand.
Technology and data service partners
Technology and data service partners help Cardinal Health, Inc. run supply chain visibility, ordering, compliance, and patient services across its 2025 fiscal year $226.8 billion in revenue base. That digital layer supports pharmacy management and outcomes services, and it helps connect customers across multiple regions and care settings.
- Improves order and inventory visibility
- Supports compliance and patient services
- Helps integrate regional customer needs
Cardinal Health’s Partners Power $222.6B in Revenue
Cardinal Health’s key partners are pharmaceutical manufacturers, hospitals, health systems, pharmacies, and logistics and tech providers. In fiscal 2025, revenue was $222.6 billion, and those ties helped support drug supply, distribution, inventory visibility, and fast delivery across care settings.
| Partner | Role | FY2025 |
|---|---|---|
| Manufacturers | Drug supply | $222.6B revenue |
| Providers | Ordering and care flow | Scale support |
| Logistics and tech | Delivery and visibility | Stockout risk cut |
What is included in the product
Detailed Word Document
A concise, real-world Business Model Canvas of Cardinal Health, Inc. covering its healthcare distribution, services, partners, channels, and revenue model.
Customizable Excel Spreadsheet
Quickly maps Cardinal Health’s business model into a clear, editable snapshot for faster analysis and decision-making.
Reference Sources
Provides a traceable source trail for Cardinal Health, Inc. that strengthens credibility and speeds confident decision-making.
Activities
Pharmaceutical distribution
Cardinal Health’s pharmaceutical distribution engine moves branded, generic, specialty, and OTC medicines from manufacturers to providers and pharmacies at massive scale. In fiscal 2025, the company reported about $222.6 billion in revenue, and this high-volume network remained its core operating driver.
Medical product manufacturing
Cardinal Health manufactures Cardinal Health-branded medical, surgical, and laboratory products, including gloves, syringes, drapes, gowns, and wound care items, and uses that output to build procedural kits for hospitals and clinics. In fiscal 2025, Cardinal Health reported about $226.8 billion in revenue, and this manufacturing base helps support supply reliability and private-label margins.
Supply chain management
Cardinal Health’s supply chain management coordinates sourcing, inventory, and delivery for hospitals, ambulatory surgery centers, clinical labs, and other providers. In FY2025, Cardinal Health reported $222.6 billion in revenue, showing the scale of its logistics role in healthcare distribution.
Specialty pharmacy services
Cardinal Health, Inc. uses specialty pharmacy services to manage high-touch drugs, patient support, medication therapy management, and outcome tracking. In fiscal 2025, the Company generated more than $220 billion in revenue, and these services help tie drug access to adherence and care coordination.
That matters because specialty medicines are a major growth area, and better support can lift fill rates and persistence for complex therapies.
- Specialty drug access and fulfillment
- Patient support and care coordination
- Medication therapy management
- Outcomes tracking for complex therapies
Radiopharmaceutical and repackaging operations
Cardinal Health runs nuclear pharmacies and radiopharmaceutical production sites, handling time-sensitive doses for imaging and cancer care. It also repackages generic drugs and OTC items, which adds controlled, lower-margin processing work and ties the Company Name deeper into regulated healthcare supply chains.
- Specialized nuclear pharmacy workflows
- Radiopharmaceutical production and delivery
- Repackaging of generics and OTC items
Cardinal Health: $222.6B Scale in Pharma, MedTech, and Specialty Care
Cardinal Health, Inc. runs three core activities: pharma distribution, medical product manufacturing, and specialty care services. In fiscal 2025, it reported $222.6 billion in revenue, showing how scale in sourcing, logistics, and regulated fulfillment drives the business.
| Key activity | FY2025 |
|---|---|
| Revenue | $222.6B |
| Core focus | Distribution, manufacturing, specialty services |
Full Document Unlocks After Purchase
Business Model Canvas
This Cardinal Health, Inc. Business Model Canvas preview is a direct view of the exact document you’ll receive after purchase. It is not a sample or mockup—what you see here is the same professionally formatted file, with the same content and layout, delivered in full. Once purchased, you’ll get instant access to this ready-to-use document exactly as previewed.
Resources
2 operating divisions
Cardinal Health runs two operating divisions—Pharmaceutical and Medical—which concentrate distribution, manufacturing, and healthcare services. In FY2025, Cardinal Health reported about $226.8 billion in revenue, with the Pharma unit carrying most scale and the Medical unit adding reach across hospitals and care sites.
Distribution network
Cardinal Health, Inc.'s distribution network is a key resource that moves pharmaceuticals and medical products across the U.S. and other markets, and it supports the company’s fiscal 2025 revenue base of more than $220 billion. Speed, accuracy, and fill-rate depend on this logistics system, which is central to serving hospitals, pharmacies, and clinics.
Medical-branded product portfolio
Cardinal Health’s branded portfolio spans 5 core lines—gloves, needles, syringes, wound care, and operating room supplies—so it supports margin and repeat buying through direct brand ownership. In FY2025, that mix helped anchor demand across clinical consumables and devices, giving Cardinal Health more control over pricing and customer loyalty.
Manufacturing and nuclear pharmacy facilities
Cardinal Health, Inc. uses manufacturing and nuclear pharmacy facilities to make medical products, sterile and non-sterile kits, and radiopharmaceuticals. In fiscal 2025, the Company reported $222.6 billion in revenue, and these regulated sites help protect quality control, capacity, and supply continuity for specialty care.
- Supports sterile and non-sterile kit production
- Supplies radiopharmaceuticals through nuclear pharmacies
- Protects regulated quality and service continuity
Workforce and healthcare expertise
Cardinal Health, Inc. relies on about 48,000 employees with pharmaceutical, medical, regulatory, and logistics skills to run its distribution, manufacturing, customer service, and compliance work. In FY2025, that human capital supported a business that generated about $226 billion in revenue, where healthcare know-how is key in a tightly regulated supply chain.
- About 48,000 employees
- Supports regulated distribution and manufacturing
- Helps protect compliance and service quality
Cardinal Health’s Core Assets Power $226.8B in FY2025 Revenue
Cardinal Health, Inc.'s key resources are its U.S. distribution network, regulated manufacturing and nuclear pharmacy sites, branded product portfolio, and about 48,000 employees. In FY2025, these assets supported about $226.8 billion in revenue and helped keep supply, quality, and service levels steady across pharmacies, hospitals, and clinics.
| Key resource | FY2025 data |
|---|---|
| Revenue | $226.8B |
| Employees | ~48,000 |
Value Propositions
Broad healthcare product access
Cardinal Health, Inc. gives customers one source for branded, generic, specialty, and OTC medicines plus medical supplies, which cuts supplier sprawl and makes buying simpler. In fiscal 2025, Cardinal Health, Inc. generated about $222.6 billion in revenue, showing the scale behind that broad access model.
Reliable supply chain execution
Cardinal Health’s reliable supply chain execution supports time-sensitive care by keeping hospitals, pharmacies, and labs stocked when demand spikes. With over $220 billion in FY2025 net sales, its scale helps lower stockout risk in regulated settings where a missed delivery can delay treatment.
Specialty care support
Cardinal Health's specialty care support helps manufacturers, providers, and patients move specialty drugs through access, therapy management, outcomes support, and pharmacy operations. In fiscal 2025, Cardinal Health reported $222.6 billion in revenue, showing the scale behind these services and their role in improving treatment execution.
Cost and operational efficiency
Cardinal Health’s bundled sourcing, distribution, and kit assembly cut customer workload and SKU complexity. In FY2025, Cardinal Health reported $222.6 billion in revenue, showing the scale behind its low-cost, high-throughput model for large provider networks.
- One order stream, less admin work
- Lower SKU sprawl for hospitals
- Scale supports tighter unit costs
Clinical product breadth and customization
Cardinal Health, Inc. combines a wide clinical catalog with customization: in fiscal 2025, it generated about $222.6 billion in revenue, including roughly $21 billion from Global Medical Products and Distribution, which covers medical consumables and procedure kits. It also adds repackaging and tailored supply chain services, helping hospitals, ambulatory centers, and home care teams get the right products in the right pack size.
- Wide consumables and procedure-kit range
- Repackaging and custom supply chain support
- Fits hospitals, clinics, and home care
Cardinal Health’s Scale-Powered Access Model Delivers $222.6B in FY2025 Revenue
Cardinal Health, Inc. bundles medicines, medical supplies, and specialty services into one buying path, which lowers supplier sprawl and cuts admin work. In fiscal 2025, it posted about $222.6 billion in revenue, showing the scale behind that access model.
| Value driver | FY2025 data |
|---|---|
| Revenue | $222.6B |
| Specialty services | Access, therapy, pharmacy ops |
Customer Relationships
Long-term B2B contracts
Cardinal Health relies on multi-year B2B contracts with providers and distributors, which helps keep demand steady and service levels consistent. In fiscal 2025, the Company generated about $222.6 billion in revenue, showing the scale that long-term healthcare supply agreements can support.
These contract structures are common in healthcare supply chains because they lock in recurring orders, pricing terms, and delivery cadence, reducing churn for both sides.
Dedicated account management
In FY2025, Cardinal Health reported $222.6 billion in revenue, and its large customers often get direct sales and account teams to tune product mix, delivery timing, and service levels. That matters for hospitals, health systems, and pharmacy customers, because Cardinal Health says it serves more than 90% of U.S. hospitals.
Consultative supply chain support
Cardinal Health supports more than 90% of U.S. hospitals, using consultative help to manage inventory, sourcing, and workflow issues in hospital and ambulatory settings. In fiscal 2025, the Company reported about $222.6 billion in revenue, and that scale helps turn procurement into an ongoing service relationship, not just a buy order.
Clinical and patient support services
Cardinal Health, Inc. uses clinical and patient support to move beyond shipping into care coordination: specialty services like medication therapy management and outcomes support help patients stay on therapy and improve adherence. In FY2025, Cardinal Health reported $222.6 billion in revenue, showing the scale behind these support services.
- Medication therapy management
- Care coordination after shipment
- Adherence and outcomes support
Digital ordering and service access
Cardinal Health, Inc. uses digital ordering and service tools so customers can place orders and track fulfillment with less manual work, which matters at FY2025 scale: revenue was about $222.6 billion. Self-service access helps frequent replenishment and supports service across thousands of sites, especially in its Pharmaceutical and Specialty Solutions network.
- Order placement and tracking are digital.
- Self-service cuts replenishment friction.
- Scale supports many customer locations.
Cardinal Health’s Sticky B2B Model Powers $222.6B Revenue
Cardinal Health, Inc. keeps customer ties sticky through multi-year B2B contracts, direct account teams, and digital ordering that cuts replenishment friction. In fiscal 2025, revenue was $222.6 billion, and the Company said it serves more than 90% of U.S. hospitals.
| Metric | FY2025 |
|---|---|
| Revenue | $222.6B |
| U.S. hospitals served | 90%+ |
| Relationship model | Contracts, account teams, digital ordering |
Channels
Direct sales force
Cardinal Health uses direct commercial teams to sell to hospitals, pharmacies, and healthcare organizations, which helps manage complex accounts and negotiated contracts. In fiscal 2025, Cardinal Health generated about $222.6 billion in revenue, and this model supports its large, contract-heavy distribution base.
Distribution centers and fulfillment network
Cardinal Health, Inc. moves pharmaceuticals and medical products through its warehouse and distribution network, which is the core channel to hospitals, pharmacies, and care sites. In fiscal 2025, it reported about $226 billion in revenue, showing how scale and fast inventory turns support broad product flow and tighter stock control.
Online ordering platforms
Online ordering platforms are a key repeat-purchase channel for Cardinal Health, Inc., especially in high-volume replenishment. In fiscal 2025, Cardinal Health reported about $222.6 billion in revenue, and digital ordering helps customers cut manual work, speed reorders, and track inventory more clearly.
Specialty pharmacy and nuclear pharmacy sites
Cardinal Health, Inc. uses specialty pharmacy and nuclear pharmacy sites to handle high-touch, regulated care for rare-disease medicines and radiopharmaceuticals. In fiscal 2025, Cardinal Health reported $222.6 billion in revenue, and these channels help move complex therapies through tightly controlled dosing, storage, and delivery steps.
- Specialty medicines need close patient support
- Nuclear pharmacy workflows are tightly regulated
- High-touch sites protect time-sensitive treatment
Customer service and field support
Cardinal Health, Inc. customer service and field support teams handle order problems, product questions, and ops issues fast, which matters when providers need urgent stock to keep care moving. This channel helps protect reliability and retention, backed by Cardinal Health's scale: about 48,000 employees and fiscal 2025 revenue above $220 billion.
- Fixes order issues fast
- Supports urgent provider needs
- Reinforces trust and retention
Cardinal Health’s Massive Distribution Engine Powers $222.6B in FY2025 Revenue
Cardinal Health, Inc. sells through direct sales teams, digital ordering, and a large warehouse network that moves products to hospitals, pharmacies, and care sites. In fiscal 2025, it generated $222.6 billion in revenue and served over 60,000 U.S. pharmacy and hospital locations.
| Channel | Role | FY2025 data |
|---|---|---|
| Direct sales | Contracts, account support | $222.6B revenue |
| Digital ordering | Fast replenishment | 60,000+ locations |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.